A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

The amyloid hypothesis of Alzheimer's disease at 25 years

Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · see citing works

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works

The blood-brain barrier: Bottleneck in brain drug development

Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798 · see citing works

Cellular uptake of the tat protein from human immunodeficiency virus

Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,782 · see citing works

Endocytosis of nanomedicines

Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181 · see citing works

The clinical use of structural MRI in Alzheimer disease

Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113 · see citing works

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202 · see citing works

Biomarkers for Alzheimer's disease: current status and prospects for the future

Blennow, K., & Zetterberg, H. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12816 · Cited by 1,000 · see citing works

Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989 · see citing works

Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

Hartley, D. M., Walsh, D. M., Ye, C., Diehl, T. S., Vasquez, S., Vassilev, P., Teplow, D. B., & Selkoe, D. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 965 · see citing works

Preparation and characterization of magnetite nanoparticles coated by amino silane

Ma, M., Zhang, Y., Yü, W., Shen, H.-Y., Zhang, H., & Gu, N. (2002) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(02)00305-9 · Cited by 870 · see citing works

LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms

Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828 · see citing works

Cell-penetrating peptides: mechanism and kinetics of cargo delivery

Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799 · see citing works

Human ATP-binding cassette (ABC) transporter family

Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-281 · Cited by 779 · see citing works

Transport of drugs across the blood–brain barrier by nanoparticles.

Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · see citing works

Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works

CNS Delivery Via Adsorptive Transcytosis

Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676 · see citing works

P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model

Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660 · see citing works

Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells

Molday, R. S., & MacKenzie, D. J. (1982) · Journal of Immunological Methods · doi:10.1016/0022-1759(82)90007-2 · Cited by 614 · see citing works

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

Hansson, O., Edelmayer, R. M., Boxer, A. L., Carrillo, M. C., Mielke, M. M., Rabinovici, G. D., Salloway, S., Sperling, R., Zetterberg, H., & Teunissen, C. E. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12756 · Cited by 607 · see citing works

Appropriate use criteria for amyloid PET: a report of the amyloid imaging task force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., Karlawish, J. H., Rowe, C. C., Carrillo, M. C., Hartley, D. M., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.002 · Cited by 603 · see citing works

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

Sabri, O., Sabbagh, M. N., Seibyl, J., Barthel, H., Akatsu, H., Ouchi, Y., Senda, K., Murayama, S., Ishii, K., Takao, M., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.004 · Cited by 602 · see citing works

Nanotoxicity of iron oxide nanoparticle internalization in growing neurons

Pisanic, T. R., Blackwell, J. D., Shubayev, V. I., Fiñones, R. R., & Jin, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.043 · Cited by 585 · see citing works

Superparamagnetic Iron Oxide Nanoparticles—Current and Prospective Medical Applications

Dulińska-Litewka, J., Łazarczyk, A., Hałubiec, P., Szafrański, O., Karnas, K., & Karewicz, A. (2019) · Materials · doi:10.3390/ma12040617 · Cited by 585 · see citing works

Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572 · see citing works

Surface modification of magnetic iron oxide nanoparticles

Zhu, N., Ji, H., Yu, P., Niu, J., Farooq, M. U., Akram, M. W., Udego, I. O., Li, H., & Niu, X. (2018) · Nanomaterials · doi:10.3390/nano8100810 · Cited by 569 · see citing works

The tangled history of mRNA vaccines

Dolgin, E. (2021) · Nature · doi:10.1038/d41586-021-02483-w · Cited by 556 · see citing works

Chemical Design of Biocompatible Iron Oxide Nanoparticles for Medical Applications

Ling, D., & Hyeon, T. (2012) · Small · doi:10.1002/smll.201202111 · Cited by 491 · see citing works

The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma

Jordan, A., Scholz, R., Maier-Hauff, K., van Landeghem, F. K. H., Waldoefner, N., Teichgraeber, U., Pinkernelle, J., Bruhn, H., Neumann, F., Thiesen, B., et al. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9059-z · Cited by 459 · see citing works

Designed synthesis and surface engineering strategies of magnetic iron oxide nanoparticles for biomedical applications

Wu, W. H., Jiang, C., & Roy, V. A. L. (2016) · Nanoscale · doi:10.1039/c6nr07542h · Cited by 420 · see citing works

Correlations of synaptic and pathological markers with cognition of the elderly

Dickson, D. W., Crystal, H. A., Bevona, C., Honer, W., Vincent, I., & Davies, P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00013-5 · Cited by 410 · see citing works

Transferrin and Transferrin Receptor Function in Brain Barrier Systems

Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394 · see citing works

Lactoferrin

Suzuki, Y. A., López, V., & Lönnerdal, B. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5371-1 · Cited by 384 · see citing works

Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment

Cui, Y., Xu, Q., Chow, P. K. H., Wang, D., & Wang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.075 · Cited by 377 · see citing works

Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications

Martins, C., Sousa, F., Araújo, F., & Sarmento, B. F. C. C. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201701035 · Cited by 366 · see citing works

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363 · see citing works

Biology and pathophysiology of the amyloid precursor protein

Zheng, H., & Koo, E. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-27 · Cited by 346 · see citing works

Truncated and modified amyloid-beta species

Kummer, M. P., & Heneka, M. T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt258 · Cited by 338 · see citing works

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

Buée, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., & Fillit, H. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294173 · Cited by 331 · see citing works

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease

Meng, Q., Wang, A., Hua, H., Jiang, Y. Y., Wang, Y., Mu, H., Wu, Z., & Sun, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151474 · Cited by 313 · see citing works

Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990–2019

Ding, C., Wu, Y., Chen, X., Chen, Y., Wu, Z., Lin, Z., Kang, D., Fang, W., & Chen, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.952161 · Cited by 312 · see citing works

The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress

Greeve, I., Hermans‐Borgmeyer, I., Brellinger, C., Kasper, D., Gómez‐Isla, T., Behl, C., Levkau, B., & Nitsch, R. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07345.2000 · Cited by 300 · see citing works

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants

Petri, B., Bootz, A., Khalansky, A. S., Hekmatara, T., Müller, R. H., Uhl, R., Kreuter, J., & Gelperina, S. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 299 · see citing works

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Sánchez‐López, E., Ettcheto, M., Egea, M. A., Espina, M., Cano, A. C., Calpena, A. C., Camins, A., Carmona-Ule, N., Silva, A. M., Souto, E. B., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0356-z · Cited by 297 · see citing works

Synthesis and characterization of polyethylene glycol (PEG) coated Fe3O4 nanoparticles by chemical co-precipitation method for biomedical applications

Anbarasu, M., Anandan, M., Chinnasamy, E., Gopinath, V., & Balamurugan, K. (2014) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2014.07.059 · Cited by 295 · see citing works

Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI)

Cheng, K. K., Chan, P. S., Fan, S., Kwan, S. M., Yeung, K. L., Wáng, Y. X. J., Chow, A. H. L., Wu, E. X., & Baum, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.005 · Cited by 293 · see citing works

Tau PET imaging: present and future directions

Saint‐Aubert, L., Lemoine, L., Chiotis, K., Leuzy, A., Rodriguez‐Vieitez, E., & Nordberg, A. K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0162-3 · Cited by 283 · see citing works

Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles

WILSON, B., Samanta, M. K., Santhi, K., KUMAR, K., Paramakrishnan, N., & Suresh, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.009 · Cited by 279 · see citing works

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

Wadghiri, Y. Z., Sigurdsson, E. M., Sadowski, M. J., Elliott, J. I., Li, Y., Scholtzova, H., Tang, C. Y., Aguinaldo, G., Pappolla, M. A., Duff, K., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10529 · Cited by 273 · see citing works

The aggregation kinetics of Alzheimer's β‐amyloid peptide is controlled by stochastic nucleation

Hortschansky, P., Schroeckh, V., Christopeit, T., Zandomeneghi, G., & Fändrich, M. (2005) · Protein Science · doi:10.1110/ps.041266605 · Cited by 266 · see citing works

Preparation and brain delivery property of biodegradable polymersomes conjugated with ox26

Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C., Gao, X., Jiang, X., & Zhu, C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.007 · Cited by 264 · see citing works

Multifunctional Nanoliposomes with Curcumin-Lipid Derivative and Brain Targeting Functionality with Potential Applications for Alzheimer Disease

Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263 · see citing works

Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers

Shaffer, J. L., Petrella, J. R., Sheldon, F. C., Choudhury, K. R., Calhoun, V. D., Coleman, R. E., Doraiswamy, P. M., & Initiative, A. D. N. (2012) · Radiology · doi:10.1148/radiol.12120010 · Cited by 255 · see citing works

Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy

Cui, Y., Zhang, M., Zeng, F., Jin, H., Xu, Q., & Huang, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10175 · Cited by 243 · see citing works

Detection of neuritic plaques in Alzheimer’s disease by magnetic resonance microscopy

Benveniste, H., Einstein, G., Kim, K. R., Hulette, C., & Johnson, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14079 · Cited by 238 · see citing works

Treatment of vascular risk factors is associated with slower decline in Alzheimer disease

Deschaintre, Y., Richard, F., Leys, D., & Pasquier, F. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b59bf3 · Cited by 232 · see citing works

Magnetic targeting of nanoparticles across the intact blood–brain barrier

Kong, S. D., Lee, J., Ramachandran, S., Eliceiri, B. P., Shubayev, V. I., Lal, R., & Jin, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.021 · Cited by 226 · see citing works

Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer’s Disease by Accelerating the Clearance of Amyloid-Beta

Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., et al. (2014) · ACS Nano · doi:10.1021/nn4058215 · Cited by 219 · see citing works

Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain

Wang, Z. H., Wang, Z., Sun, C., Wang, C. Y., Jiang, T., & Wang, S. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.104 · Cited by 214 · see citing works

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213 · see citing works

Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection

Yang, L. L., Rieves, D., & Ganley, C. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1208061 · Cited by 202 · see citing works

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Molinuevo, J. L., Blennow, K., Dubois, B., Engelborghs, S., Lewczuk, P., Perret‐Liaudet, A., Teunissen, C. E., & Parnetti, L. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.003 · Cited by 198 · see citing works

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

Jack, C. R., Garwood, M., Wengenack, T. M., Borowski, B., Curran, G. L., Lin, J., Adriany, G., Gröhn, O. H. J., Grimm, R. C., & Poduslo, J. F. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20266 · Cited by 196 · see citing works

Tau protein, the paired helical filament and Alzheimer's disease

Goedert, M., Klug, A., & Crowther, R. A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s323 · Cited by 195 · see citing works

Reaction to a Dementia Diagnosis in Individuals with Alzheimer's Disease and Mild Cognitive Impairment

Carpenter, B. D., Xiong, C., Porensky, E. K., Lee, M. M., Brown, P. J., Coats, M. A., Johnson, D. K., & Morris, J. C. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01600.x · Cited by 194 · see citing works

Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease

Viola, K. L., Sbarboro, J., Sureka, R., De, M., Bicca, M. A., Wang, J., Vasavada, S. R., Satpathy, S., Wu, S., Joshi, H. M., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.254 · Cited by 192 · see citing works

Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients

Grauer, O. M., Jaber, M., Heß, K., Weckesser, M., Schwindt, W., Maring, S., Wölfer, J., & Stummer, W. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03005-x · Cited by 186 · see citing works

Hybrid, Silica-Coated, Janus-Like Plasmonic-Magnetic Nanoparticles

Sotiriou, G. A., Hirt, A. M., Lozach, P., Teleki, A., Krumeich, F., & Pratsinis, S. E. (2011) · Chemistry of Materials · doi:10.1021/cm200399t · Cited by 185 · see citing works

Ten Things You Might Not Know about Iron Oxide Nanoparticles

Daldrup-Link, H. E. (2017) · Radiology · doi:10.1148/radiol.2017162759 · Cited by 176 · see citing works

PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice

Huang, N., Lü, S., Liu, X., Zhu, J., Wang, Y., & Liu, R. (2017) · Oncotarget · doi:10.18632/oncotarget.20944 · Cited by 170 · see citing works

Beta-amyloid imaging with florbetaben

Sabri, O., Seibyl, J., Rowe, C., & Barthel, H. (2015) · Clinical and translational imaging · doi:10.1007/s40336-015-0102-6 · Cited by 167 · see citing works

Iron oxide nanoparticles stabilized with a bilayer of oleic acid for magnetic hyperthermia and MRI applications

Soares, P. I. P., Laia, C. A. T., Carvalho, A., Pereira, L. C. J., Coutinho, J. T., Ferreira, I., Novo, C., & Borges, J. P. (2016) · Applied Surface Science · doi:10.1016/j.apsusc.2016.04.181 · Cited by 167 · see citing works

B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide

Liu, Z., Gao, X., Kang, T., Jiang, M., Miao, D., Gu, G., Hu, Q., Song, Q., Yao, L., Tu, Y., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400055h · Cited by 164 · see citing works

Receptor-Mediated Endocytosis and Brain Delivery of Therapeutic Biologics

Xiao, G., & Gan, L.-S. L. (2013) · International Journal of Cell Biology · doi:10.1155/2013/703545 · Cited by 163 · see citing works

Influence of the Physiochemical Properties of Superparamagnetic Iron Oxide Nanoparticles on Amyloid β Protein Fibrillation in Solution

Mahmoudi, M., Quinlan-Pluck, F., Monopoli, M. P., Sheibani, S., Vali, H., Dawson, K. A., & Lynch, I. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300196n · Cited by 159 · see citing works

Remote control of the permeability of the blood–brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery

Tabatabaei, S. N., Girouard, H., Carret, A., & Martel, S. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.027 · Cited by 156 · see citing works

Nanotheranostics: Congo Red/Rutin‐MNPs with Enhanced Magnetic Resonance Imaging and H₂O₂‐Responsive Therapy of Alzheimer's Disease in APPswe/PS1dE9 Transgenic Mice

Hu, B., Dai, F., Fan, Z., Ma, G., Tang, Q., & Zhang, X. (2015) · Advanced Materials · doi:10.1002/adma.201502227 · Cited by 155 · see citing works

Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of Alzheimer disease

Bana, L., Minniti, S., Salvati, E., Sesana, S., Zambelli, V., Cagnotto, A., Orlando, A., Cazzaniga, E., Zwart, R., Scheper, W., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.12.001 · Cited by 151 · see citing works

Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood–Brain Barrier for Effective Treatment of Alzheimer’s Disease

Arora, S., Layek, B., & Singh, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00461 · Cited by 149 · see citing works

ApoE3 Mediated Poly(butyl) Cyanoacrylate Nanoparticles Containing Curcumin: Study of Enhanced Activity of Curcumin against Beta Amyloid Induced Cytotoxicity Using In Vitro Cell Culture Model

Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900306x · Cited by 147 · see citing works

Surface modified PLGA nanoparticles for brain targeting of Bacoside-A

Jose, S., Sowmya, S. D., Cinu, T. A., Aleykutty, N., Thomas, S., & Souto, E. B. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.06.024 · Cited by 146 · see citing works

Central nervous system delivery of molecules across the blood-brain barrier

Gosselet, F., Loiola, R. A., Roig, A., Rosell, A., & Culot, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104952 · Cited by 141 · see citing works

Preparation, characterization,<i>in vivo</i>biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting

Md, S., Ali, M., Baboota, S., Sahni, J. K., Bhatnagar, A., & Ali, J. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.758130 · Cited by 138 · see citing works

A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells

Omid Veiseh, A., Kievit, F. M., Gunn, J., Ratner, B. D., & Zhang, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.003 · Cited by 130 · see citing works

Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology

Moura, R. P., Martins, C., Pinto, S. F. T., Sousa, F., & Sarmento, B. F. C. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583205 · Cited by 127 · see citing works

Fabrication of active targeting lipid nanoparticles: Challenges and perspectives

Menon, I., Zaroudi, M., Zhang, Y., Aisenbrey, E. A., & Hui, L. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100299 · Cited by 124 · see citing works

Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems

Poudel, P., & Park, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040835 · Cited by 124 · see citing works

Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents

Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001582 · Cited by 114 · see citing works

Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging

Wadghiri, Y. Z., Li, J., Wang, J., Hoang, D. M., Sun, Y., Xu, H., Tsui, W., Li, Y., Boutajangout, A., Wang, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057097 · Cited by 114 · see citing works

Targeting liposomes with protein drugs to the blood–brain barrier in vitro

Visser, C. C., Stevanović, S., Voorwinden, L. H., van Bloois, L., Gaillard, P. J., Danhof, M., Crommelin, D. J. A., & de Boer, A. G. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.008 · Cited by 114 · see citing works

Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles

Amiri, H., Bordonali, L., Lascialfari, A., Wan, S., Monopoli, M. P., Lynch, I., Laurent, S., & Mahmoudi, M. (2013) · Nanoscale · doi:10.1039/c3nr00345k · Cited by 108 · see citing works

Effects of surfactants on the magnetic properties of iron oxide colloids

Soares, P. I. P., Alves, A. M. R., Pereira, L. C. J., Coutinho, J. T., Ferreira, I., Novo, C., & Borges, J. P. (2014) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2013.12.045 · Cited by 106 · see citing works

SPION-Enhanced Magnetic Resonance Imaging of Alzheimer's Disease Plaques in AβPP/PS-1 Transgenic Mouse Brain

Sillerud, L. O., Solberg, N. O., Chamberlain, R., Orlando, R. A., Heidrich, J. E., Brown, D. C., Brady, C. I., Jagt, T. A. V., Garwood, M., & Jagt, D. L. V. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121171 · Cited by 103 · see citing works

Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma

Ganipineni, L. P., Učakar, B., Joudiou, N., Bianco, J. I., Danhier, P., Zhao, M., Bastiancich, C., Gallez, B., Danhier, F., & Véronique Préat, A. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s165184 · Cited by 100 · see citing works

Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery Across The Blood–Brain Barrier

Tosi, G., Fano, R. A., Bondioli, L., Badiali, L., Benassi, R., Rivasi, F., Ruozi, B., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.11 · Cited by 99 · see citing works

Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease

Manek, E., Darvas, F., & Petroianu, G. A. (2020) · Molecules · doi:10.3390/molecules25204866 · Cited by 97 · see citing works

Design and engineering of magneto-responsive devices for cancer theranostics: Nano to macro perspective

Soares, P. I. P., Romão, J., Matos, R. J. R., Silva, J. A. M. D. C., & Borges, J. P. (2020) · Progress in Materials Science · doi:10.1016/j.pmatsci.2020.100742 · Cited by 95 · see citing works

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

Pinto, M., Silva, V., Barreiro, S., Silva, R. V. D. S., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 94 · see citing works

In Vivo Visualization of Senile‐Plaque‐Like Pathology in Alzheimer's Disease Patients by MR Microscopy on a 7T System

Nakada, T., Matsuzawa, H., Igarashi, H., Fujii, Y., & Kwee, I. L. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00179.x · Cited by 93 · see citing works

Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery

Vilella, A., Belletti, D., Sauer, A. K., Hagmeyer, S., Sarowar, T., Masoni, M., Stasiak, N., Mulvihill, J. J., Ruozi, B., Forni, F., et al. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.12.006 · Cited by 92 · see citing works

Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

Parrasia, S., Szabó, I., Zoratti, M., & Biasutto, L. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00523 · Cited by 90 · see citing works

Magnetoliposomes as magnetic resonance imaging contrast agents

Soenen, S. J., Velde, G. V., Ketkar-Atre, A., Himmelreich, U., & Cuyper, M. D. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.122 · Cited by 87 · see citing works

Cerebral clearance of human amyloid‐β peptide (1–40) across the blood–brain barrier is reduced by self‐aggregation and formation of low‐density lipoprotein receptor‐related protein‐1 ligand complexes

Ito, S., Ohtsuki, S., Kamiie, J., Nezu, Y., & Terasaki, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04938.x · Cited by 85 · see citing works

Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibition

Ruan, Y., Xiong, Y., Fang, W., Yu, Q., Mai, Y., Cao, Z., Wang, K., Lei, M., Xu, J., Liu, Y., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01524-4 · Cited by 85 · see citing works

Development of multiple-layer polymeric particles for targeted and controlled drug delivery

Koppolu, B., Rahimi, M., Nattama, S., Wadajkar, A. S., & Nguyen, K. T. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.07.008 · Cited by 82 · see citing works

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective

Ahmad, J., Akhter, S., Rizwanullah, M., Khan, M. A., Pigeon, L., Addo, R. T., Greig, N. H., Midoux, P., Pichon, C., & Kamal, M. A. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170508121031 · Cited by 81 · see citing works

Uptake and Transport of Superparamagnetic Iron Oxide Nanoparticles through Human Brain Capillary Endothelial Cells

Thomsen, L. B., Linemann, T., Pondman, K. M., Lichota, J., Kim, K. S., Pieters, R. J., Visser, G. M., & Moos, T. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400093z · Cited by 80 · see citing works

Bifunctional magnetopolymersomes of iron oxide nanoparticles and carboxymethylcellulose conjugated with doxorubicin for hyperthermo-chemotherapy of brain cancer cells

Carvalho, S. M., Leonel, A. G., Mansur, A. A. P., Carvalho, I. C., Krambrock, K., & Mansur, H. S. (2019) · Biomaterials Science · doi:10.1039/c8bm01528g · Cited by 80 · see citing works

Superparamagnetic iron oxide nanoparticles combined with NGF and quercetin promote neuronal branching morphogenesis of PC12 cells

Katebi, S., Esmaeili, A., Ghaedi, K., & Zarrabi, A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s191878 · Cited by 79 · see citing works

Enhanced MRI T 2 Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles

Thapa, B., Diaz-Diestra, D., Beltran‐Huarac, J., Weiner, B. R., & Morell, G. (2017) · Nanoscale Research Letters · doi:10.1186/s11671-017-2084-y · Cited by 78 · see citing works

Blood-brain Barrier Crossing using Magnetic Stimulated Nanoparticles

Chen, J., Yuan, M., Madison, C. A., Eitan, S., & Wang, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.007 · Cited by 73 · see citing works

Central and Peripheral Administration of Antisense Oligonucleotide Targeting Amyloid-β Protein Precursor Improves Learning and Memory and Reduces Neuroinflammatory Cytokines in Tg2576 (AβPPswe) Mice

Farr, S. A., Erickson, M. A., Niehoff, M. L., Banks, W. A., & Morley, J. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131883 · Cited by 72 · see citing works

Potential applications of magnetic particles to detect and treat Alzheimer's disease

Busquets, M. A., Sabaté, R., & Estelrich, J. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-538 · Cited by 72 · see citing works

Orlistat and Antisense-miRNA-Loaded PLGA-PEG Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy

Bhargava-Shah, A., Foygel, K., Devulapally, R., & Paulmurugan, R. (2016) · Nanomedicine · doi:10.2217/nnm.15.193 · Cited by 70 · see citing works

Interaction between cerebrovascular disease and Alzheimer pathology

Saito, S., & Ihara, M. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000239 · Cited by 69 · see citing works

Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain

Ahlschwede, K. M., Curran, G. L., Rosenberg, J. T., Grant, S. C., Sarkar, G., Jenkins, R. B., Ramakrishnan, S., Poduslo, J. F., & Kandimalla, K. K. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.09.010 · Cited by 68 · see citing works

A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer’s Disease

Fantoni, E. R., Chalkidou, A., O’ Brien, J. T., Farrar, G., & Hammers, A. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171093 · Cited by 68 · see citing works

Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process

Mirsadeghi, S., Shanehsazzadeh, S., Atyabi, F., & Dinarvand, R. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.10.026 · Cited by 67 · see citing works

Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models

Ghiyamihoor, F., Moghadam, A. J., Shakeri‐Zadeh, A., Bakhtiyari, M., Shabani, R., & Mehdizadeh, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.035 · Cited by 65 · see citing works

Multimodal Nanoprobes to Target Cerebrovascular Amyloid in Alzheimer’s Disease Brain

Jaruszewski, K. M., Curran, G. L., Swaminathan, S. K., Rosenberg, J. T., Grant, S. C., Ramakrishnan, S., Lowe, V. J., Poduslo, J. F., & Kandimalla, K. K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.075 · Cited by 64 · see citing works

Dual ligand immunoliposomes for drug delivery to the brain

Loureiro, J. A., Gomes, B., Fricker, G., Cardoso, I., Ribeiro, C. A., Gaiteiro, C., Coelho, M. A. N., Pereira, M. D. C., & Rocha, S. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.067 · Cited by 64 · see citing works

Surface Modification of Iron Oxide-Based Magnetic Nanoparticles for Cerebral Theranostics: Application and Prospection

Wu, Y., Lü, Z., Li, Y., Yang, J., & Zhang, X. (2020) · Nanomaterials · doi:10.3390/nano10081441 · Cited by 61 · see citing works

Integration of gadolinium in nanostructure for contrast enhanced‐magnetic resonance imaging

Marasini, R., Nguyen, T. D. T., & Aryal, S. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1580 · Cited by 61 · see citing works

Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

Heurling, K., Leuzy, A., Zimmer, E. R., Lubberink, M., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3208-1 · Cited by 59 · see citing works

Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.

Kouyoumdjian, H., Zhu, D. C., El-Dakdouki, M. H., Lorenz, K., Chen, J.-J., Li, W., & Huang, X. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn3002015 · Cited by 59 · see citing works

Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer’s

Lopez‐Barbosa, N., Garcia, J. G., Cifuentes, J., Castro, L. M., Vargas, F., Ostos, C., Cardona‐Gómez, G. P., Hernández, A. M., & Cruz, J. C. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1775724 · Cited by 59 · see citing works

Peptide Shuttles for Blood–Brain Barrier Drug Delivery

Sánchez‐Navarro, M., & Giralt, E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091874 · Cited by 56 · see citing works

&lt;p&gt;Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer’s Disease&lt;/p&gt;

Liu, X.-G., Zhang, L., Lu, S., Liu, D.-Q., Zhang, L.-X., Yu, X.-L., & Liu, R.-T. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s240953 · Cited by 55 · see citing works

Passage of Magnetic Tat-Conjugated Fe3O4@SiO2 Nanoparticles Across In Vitro Blood-Brain Barrier

Zhao, X., Shang, T., Zhang, X., Ye, T., Wang, D., & Rei, L. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-016-1676-2 · Cited by 54 · see citing works

Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?

Cavaco, M. C., Gaspar, D., Castanho, M. A. R. B., & Neves, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010062 · Cited by 54 · see citing works

Functionalization with TAT-Peptide Enhances Blood-Brain Barrier Crossing In vitro of Nanoliposomes Carrying a Curcumin-Derivative to Bind Amyloid-Β Peptide

Sancini, G. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000171 · Cited by 54 · see citing works

Brain drug delivery by adsorption-mediated transcytosis

Zhu, X., Jin, K., Huang, Y., & Pang, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00007-x · Cited by 54 · see citing works

A Conditionally Releasable “Do not Eat Me” CD47 Signal Facilitates Microglia‐Targeted Drug Delivery for the Treatment of Alzheimer's Disease

Zhang, L., Liu, X., Liu, D., Yu, X., Zhang, L. L., Zhu, J., Lü, S., & Liu, R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910691 · Cited by 53 · see citing works

Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries

Hülsermann, U., Hoffmann, M. M., Massing, U., & Fricker, G. (2009) · Journal of drug targeting · doi:10.1080/10611860903105986 · Cited by 49 · see citing works

Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease

Larbanoix, L., Burtéa, C., Laurent, S., LEUVEN, F. V., Toubeau, G., Elst, L. V., & Müller, R. N. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.021 · Cited by 49 · see citing works

Brain-Targeted Delivery of Trans-Activating Transcriptor-Conjugated Magnetic PLGA/Lipid Nanoparticles

Wen, X., Wang, K., Zhao, Z., Zhang, Y., Sun, T., Zhang, F., Wu, J. H., Fu, Y., Du, Y., Zhang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106652 · Cited by 44 · see citing works

In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood–brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging

Ansciaux, E., Burtéa, C., Laurent, S., Crombez, D., Nonclercq, D., Elst, L. V., & Müller, R. N. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1626 · Cited by 42 · see citing works

Antibody delivery through the blood-brain barrier

Bickel, U. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00005-r · Cited by 39 · see citing works

Nanoparticles as Contrast Agents for The Diagnosis of Alzheimer’s Disease: A Systematic Review

Ulanova, M., Poljak, A., Wen, W. X., Bongers, A., Gloag, L., Gooding, J. J., Tilley, R. D., Sachdev, P. S., & Braidy, N. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0316 · Cited by 39 · see citing works

Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents

Garello, F., Svenskaya, Y. I., Parakhonskiy, B. V., & Filippi, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061132 · Cited by 38 · see citing works

Enhanced magnetic properties and MRI performance of bi-magnetic core–shell nanoparticles

Arteaga-Cardona, F., Santillán-Urquiza, E., de la Presa, P. M., Hidalgo-Tobón, S., Pal, U., Horta‐Fraijo, P., Yacamán, M. J., Lozada‐Ramírez, J. D., Ivkov, R., Ángulo-Molina, A., et al. (2016) · RSC Advances · doi:10.1039/c6ra14265f · Cited by 36 · see citing works

Improving Sensitivity and Specificity of Amyloid-β Peptides and Tau Protein Detection with Antibiofouling Magnetic Nanoparticles for Liquid Biopsy of Alzheimer’s Disease

Li, Y., Lim, E., Fields, T., Wu, H. C., Xu, Y., Wang, Y. A., & Mao, H. Z. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00086 · Cited by 36 · see citing works

Glycopeptide analgesics

Polt, R. L., & Palian, M. M. (2001) · Drugs of the Future · doi:10.1358/dof.2001.026.06.668342 · Cited by 26 · see citing works

Tumour cells on neighbourhood watch

Sontheimer, H. W. (2015) · Nature · doi:10.1038/nature15649 · Cited by 25 · see citing works

Nanomedicine and the Nervous System

(2012) · CRC Press eBooks · doi:10.1201/b11835 · Cited by 25 · see citing works

Magnetic Nanoparticles as In Vivo Tracers for Alzheimer’s Disease

Sharma, B., & Pervushin, K. V. (2020) · Magnetochemistry · doi:10.3390/magnetochemistry6010013 · Cited by 24 · see citing works

Taming tangled tau

Eisenberg, D. S., & Sawaya, M. R. (2017) · Nature · doi:10.1038/nature23094 · Cited by 23 · see citing works

Dual-Targeted Magnetic Mesoporous Silica Nanoparticles Reduce Brain Amyloid-β Burden via Depolymerization and Intestinal Metabolism

Liu, N., Liang, X., Yang, C., Hu, S., Luo, Q., & Luo, H. (2022) · Theranostics · doi:10.7150/thno.76574 · Cited by 21 · see citing works

Transferrin-conjugated drug/dye-co-encapsulated magnetic nanocarriers for active-targeting fluorescent/magnetic resonance imaging and anti-tumor effects in human brain tumor cells

Wang, X., Chang, Y., Zhang, D., Tian, B., Yang, Y., & Wei, F. (2016) · RSC Advances · doi:10.1039/c6ra20903c · Cited by 20 · see citing works

Novel magnetic beads with improved performance for Alzheimer’s disease biomarker detection

Toyos‐Rodríguez, C., Llamedo-González, A., Pando, D., García, S., García, J. Á., Alonso, F. J. G., & de la Escosura‐Muñiz, A. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107211 · Cited by 18 · see citing works

Heparin Nanoparticles for β Amyloid Binding and Mitigation of β Amyloid Associated Cytotoxicity

Wang, P., Kouyoumdjian, H., Zhu, D. C., & Huang, X. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.07.020 · Cited by 16 · see citing works

PEGylated Nanoparticles as a Versatile Drug Delivery System

Mohapatra, P., Singh, D., & Sahoo, S. K. (2021) · Wiley eBooks · doi:10.1002/9783527832095.ch10 · Cited by 14 · see citing works

Application of Hyperthermia for Cancer Treatment: Synthesis and Characterization of Magnetic Nanoparticles and their internalization on Tumor Cell Lines

Chaparro, C. I. P., Loureiro, L. R., Valente, M. A., Videira, P. A., Borges, J. P., & Soares, P. I. P. (2019) · IEEE Portuguese Meeting on Bioengineering · doi:10.1109/enbeng.2019.8692485 · Cited by 12 · see citing works

Global analysis of neurological disease: burden and benefit

Neurology, T. L. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30338-1 · Cited by 12 · see citing works

Effect of Magnetic Tacrine-Loaded Chitosan Nanoparticles on Spatial Learning, Memory, Amyloid Precursor Protein and Seladin-1 Expression in the Hippocampus Of Streptozotocin-Exposed Rats

Hassanzadeh, G., Zahra, F., Khanmohammadi, M., Elmizadeh, H., Mohammad, S., Kosar, N., Zahra, H., Mahakizadeh, S., Zendedel, A., Cordian, B., et al. (2016) · International Clinical Neuroscience Journal · doi:10.22037/icnj.v3i1.12358 · Cited by 11 · see citing works

Marine Biomaterials

(2022) · Springer eBooks · doi:10.1007/978-981-16-4787-1 · Cited by 9 · see citing works

The Bridge Between Nanotechnology and Neuroscience: Neuro-Nanomedicine

Tosi, G., Ruozi, B., Belletti, D., Badiali, L., & Vandelli, M. A. (2012) · Journal of Nanoneuroscience · doi:10.1166/jns.2012.1013 · Cited by 3 · see citing works

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment

Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 528 · see citing works

Nanotechnology in healthcare, and its safety and environmental risks

Ma, X., Tian, Y., Yang, R., Wang, H., Allahou, L. W., Chang, J., Williams, G. R., Knowles, J. C., & Poma, A. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02901-x · Cited by 362 · see citing works

Magnetic Nanoparticles: Synthesis, Characterization, and Their Use in Biomedical Field

STIUFIUC, G., & Stiufiuc, R. I. (2024) · Applied Sciences · doi:10.3390/app14041623 · Cited by 150 · see citing works

Nanoparticle Strategies for Treating CNS Disorders: A Comprehensive Review of Drug Delivery and Theranostic Applications

Toader, C., Dumitru, A. V., Eva, L., Șerban, M., Covache-Busuioc, R.-A., & Ciurea, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413302 · Cited by 70 · see citing works

Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics

Gao, L., Wang, J., & Bi, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s549893 · Cited by 52 · see citing works

Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review

Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60 · see citing works

Enhancing the magnetic properties of superparamagnetic iron oxide nanoparticles using hydrothermal treatment for magnetic hyperthermia application

Martins, C., Rolo, C., Cacho, V. R. G., Pereira, L. C. J., Borges, J. P., Silva, J. A. M. D. C., Vieira, T., & Soares, P. I. P. (2025) · Materials Advances · doi:10.1039/d4ma01120a · Cited by 43 · see citing works

Tau‐targeting nanoparticles for treatment of Alzheimer's disease

Pawar, S., Rauf, M. A., Abdelhady, H. G., & Iyer, A. K. (2024) · Exploration · doi:10.1002/exp.20230137 · Cited by 36 · see citing works

Cutting-edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease

Inamdar, A., Gurupadayya, B., Halagali, P., Nandakumar, S., Pathak, R., Singh, H., & Sharma, H. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128344571241018154506 · Cited by 26 · see citing works

Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease

Li, J., Guo, L., Cai, W., Mei, J., Liu, J., & Liu, Y. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2645830 · Cited by 14 · see citing works

From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics

Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13 · see citing works

Iron Overload in Brain: Transport Mismatches, Microbleeding Events, and How Nanochelating Therapies May Counteract Their Effects

Ficiarà, E., Stura, I., Vernone, A., Silvagno, F., Cavalli, R., & Guiot, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042337 · Cited by 11 · see citing works

Functionalized Magnetic Nanoparticles: Can They Revolutionize the Treatment of Neurodegenerative Disorders?

Zahariev, N., Boyuklieva, R., Penkov, D., Lukova, P., & Katsarov, P. (2025) · Materials · doi:10.3390/ma18184302 · Cited by 9 · see citing works

Pathways, Mechanisms, and Therapeutic Strategies of Neurotoxicity Induced by Micro- and Nanoplastics

Yan, M., Chen, Y., Tao, Y., Wang, H., Tian, X., & Wang, X. (2025) · Brain Sciences · doi:10.3390/brainsci15121345 · Cited by 5 · see citing works

Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions

Satyanarayanan, S. K., Han, Z., Xiao, J., Yuan, Q., Yung, W., Ke, Y., Chang, R. C., Zhu, M. H., Su, H., Su, K. P., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.007 · Cited by 5 · see citing works

Current trends in advanced imaging modalities for the early diagnosis of Alzheimer's disease

Zhang, X., & Xue, P. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111628 · Cited by 4 · see citing works

Overcoming the blood–brain barrier in Alzheimer's disease: translational perspectives on advanced drug delivery platforms

Roamcharern, N., & Yubolphan, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1810486 · Cited by 4 · see citing works

Advances in Parenteral Nanocarriers and Delivery Devices: A Comprehensive Review

Kapoor, D. U., Prajapati, B. G., Bhattacharya, S., Singhai, N. J., & Maheshwari, R. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128338217250114073640 · Cited by 4 · see citing works

Innovations in Nanobot and Microbot Propulsion for Targeted CNS Drug Delivery Across the Blood–Brain Barrier

Athira Nair, K., Siva Kumar, B., Reddy, S. G., & Kugabalasooriar, S. (2026) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2025.2612631 · Cited by 4 · see citing works

Frontiers in neurodegeneration: Biomolecular triggers, diagnostic biomarkers, and smart nanotherapeutics

Tiwari, V., Kulyal, H., & Tiwari, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107797 · Cited by 4 · see citing works

Safety of ferrite nanoparticles for biomedical applications: Cyto- and genotoxic effects of MxFe3-xO4 (M = Fe, Zn, Mn) in an Advanced 3D human hepatic in vitro model

Iza, R., Gallo-Cordova, A., Morales, M. P., Ovalle, M. A. M., Goya, G. F., Kološa, K., Hočevar, D., Žegura, B., & Štern, A. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118950 · Cited by 3 · see citing works

Characteristics and Antitumor Activity of Doxorubicin-Loaded Multifunctional Iron Oxide Nanoparticles in MEC1 and RM1 Cell Lines

Maisuradze, N., Kekutia, S., Markhulia, J., Tsertsvadze, T., Mikelashvili, V., Saneblidze, L., Chkhaidze, N., Horváth, Z. E., Almásy, L., & Mitskevichi, N. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15120364 · Cited by 3 · see citing works

Converging Structural Biology and Nanotechnology to Decipher and Target Alzheimer’s Disease: From Atomic Insights to Clinical Translation

Patne, A. Y., Bagban, I., & Suryawanshi, M. V. (2025) · BioChem · doi:10.3390/biochem5040040 · Cited by 2 · see citing works

Nanomedicine approaches for Alzheimer’s disease: Advances in drug delivery and theranostic applications

Bhukta, P., Sahu, P. K., & Acharya, B. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100495 · Cited by 2 · see citing works

Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions

Zorkina, Y., Abramova, O., Zubkov, E., Gurina, O., & Ushakova, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083560 · Cited by 1 · see citing works

CNS Delivery Systems Based on Nanotechnology with Particular Attention to Parkinson's and Alzheimer's Disease –A Review

Ahmad, M. M., Alshammari, A. O. S., Alshammari, M. A., Alshammari, H. O. A., Aldhabi, B. M., Alruwaytie, M. Q., & Al-hejaili, O. D. (2024) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822306813240516113807 · Cited by 1 · see citing works

Superparamagnetic iron oxide-loaded PLGA nanoparticles: Tailoring properties for theranostic applications

Chaparro, C. I. P., Fernández‐Méndez, L., Pereira, L. C. J., Ramos‐Cabrer, P., Borges, J. P., Castanho, M. A. R. B., Neves, V., & Soares, P. I. P. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.112599 · Cited by 1 · see citing works

Therapeutic Potential of a Gadolinium Chelate Complex Conjugated with Vanillic Acid for Alzheimer’s Disease

Jeon, M., Sung, B., Lee, J. W., Hwang, D. W., Lee, E., Kim, H., Kim, D., Kim, D.-G., & Chang, Y. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00316 · Cited by 1 · see citing works

Investigating Drug Release and Antitumor Activity in Experimental MEC1 and RM1 Cell Lines Using Multifunctional Iron Oxide NanoparticlesPreprint

Maisuradze, N., Kekutia, S., Markhulia, J., Tsertsvadze, T., Mikelashvili, V., Saneblidze, L., Chkhaidze, N., Horváth, Z. E., Almásy, L., & Mitskevichi, N. (2024) · Preprints.org · doi:10.20944/preprints202408.1637.v1 · Cited by 1 · see citing works

Optimizing magnetic hyperthermia for melanoma: the role of nanoparticle uptake inhibition

Simões, B. T., Chaparro, C. I. P., Vieira, T., Valente, M. A., Cavaco, M. C., Neves, V., Silva, J. A. M. D. C., Borges, J. P., Almeida, F. V., & Soares, P. I. P. (2025) · Nano Express · doi:10.1088/2632-959x/adbde1

Nano-healing: Exploring the Therapeutic Potentials of Nanomedicine for CNS Disorders

Ahmad, F. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128362577250227081919

Targeting of β-Amyloid Peptide Fibers, a Biomarker of Alzheimer’s Disease, by Designing Specifically Functionalized Iron Oxide Nanoparticles

Porras, G. R. G., Brison, A., Becker, A., Calvé, S. L., David, M., Ulrich, G., Mazan, V., Schmutz, M., Bigo−Simon, A., Mertz, D., et al. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c03459

Nanotechnology and Secondary Metabolites

Kotha, K. K., Chandrakala, A. N., Kumarachari, R. K., Bukke, S. P. N., Sarangapani, P., & Karpagavalli, L. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch012

Early detection of Alzheimer’s disease: Progress, challenges, and future outlook

Albayrak, A. (2026) · Disiplinlerarası Yenilik Araştırmaları Dergisi · doi:10.56723/dyad.1737746

Ultrasound- and magnetic field-triggered destruction of insulin- and lysozyme-derived amyloid fibrils via biogenic magnetosomes

Molčan, M., Fedorova, V., Romanovová, M., Bielas, R., Ratajczak, F., Józefczak, A., & Šipošová, K. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115670

Gene Therapy and RNA-Based Innovations for Management of Alziemer's

Tiwari, J., Anand, P., Kumar, D., & Singh, S. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010011

Tiny Titans, big promise: Nanotechnology and microRNA in the fight against Alzheimer’s disease

Nakum, B., Vejpara, D., Faldu, K. G., Soni, R., & Shah, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103149

Nanotechnology for Alzheimer's disease: bridging pathobiology, delivery barriers and multi‐target therapy

M‐Atoom, A., Ahmed, M. H., Al-Hasnaawei, S., Malathi, H., Maharana, L., Nanda, A., Arora, V., & Singh‐Chauhan, A. (2026) · Polymer International · doi:10.1002/pi.70141

Advances in neurotherapeutics for neurodegeneration

Kapur, D., Vashisht, D., & Singh, T. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00279-0

Advances in non-invasive monitoring of drug delivery for neurodegenerative disorders

Choi, J. Y., & Heiss, J. D. (2026) · Expert Review of Medical Devices · doi:10.1080/17434440.2026.2743929

Magnetic Nanoparticles for Theranostic Nanomedicine: A Novel Barrier-Route-Stimulus Design Framework, Complexity-Translatability Heuristic and Translational Evidence in Seven Disease Contexts

Sarkar, R., Bora, K. S., & Dewangan, H. K. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-11073-0

Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems

Altinoglu, G., & Adalı, T. (2019) · Current Drug Targets · doi:10.2174/1389450120666191118123151 · Cited by 42 · see citing works

Neurotherapeutic applications of nanoparticles in Alzheimer’s disease

Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219 · see citing works

Nanoparticles – a novel theranostic approach to treat alzheimer’s disease

Bashir, W. Q., & Shahzadi, S. (2022) · Journal of Applied Biotechnology & Bioengineering · doi:10.15406/jabb.2022.09.00312 · Cited by 1 · see citing works

Therapeutic approaches of magnetic nanoparticles for the central nervous system

Dilnawaz, F., & Sahoo, S. K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.06.008 · Cited by 69 · see citing works

Targeted Delivery Modalities in Combination with Biofunctionalized Metallic Nanoparticles (MNPs): Combating Amyloid Plaques

Kushwaha, N., Panjwani, D., Akarte, K., Patel, S., Ahlawat, P., Kesarla, R., Yadav, M. R., & Patel, A. (2025) · Current Nanoscience · doi:10.2174/0115734137361817250325071654 · Cited by 3 · see citing works